An observational study in Prematurity, Respiratory Distress Neonatal and Oxygen Delivery, sponsored by King's College Hospital NHS Trust. Not yet recruiting at 1 site in United Kingdom. Open to participants aged 1 Year to 5 Years. Per ClinicalTrials.gov, last updated 2026-10-14.
Sponsored by King's College Hospital NHS Trust · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 100 studies in Premature Birth with a site in United Kingdom — 19 open to participants now, 25 under way, 1 of them phase 3. Premature Birth · United Kingdom.
Among the 100 studies in Premature Birth with a site in United Kingdom, this one is the 30th largest by planned enrollment of the 46 observational ones that give a count, is one of 3 that started in 2026, is one of 46 observational ones, reaches primary completion later than 21 of the 24 other live ones, and was the 100th registered.
2,557 studies on the registry are indexed under Premature Birth; 504 are open to participants now.
Browse Premature Birth studies →19 of the 100 studies in Premature Birth with a site in United Kingdom are open now. Recruiting first, the newest first:
King's College Hospital NHS Trust · Sites in United Kingdom
Ages 22 wk–34 wk
Imperial College Healthcare NHS Trust · Sites in United Kingdom
Ages 23 wk–30 wk
Imperial College London · Sites in United Kingdom
Ages up to 30 wk
South Tees Hospitals NHS Foundation Trust · Sites in United Kingdom
Ages 22 wk–32 wk
Queen Mary University of London · Sites in United Kingdom
Ages 18+ · Women only
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 318 Premature Birth studies recruiting now, 88 (28%) set no upper age limit and 226 (71%) stop at 75 or younger; 243 take children under 18; 104 take healthy volunteers.
This study: 1 Year to 5 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
100 studies; the count open now beside each. This study's row is marked.
First in 2000; this study’s year is marked. 3 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 60 is below the median of 120 across 809 observational studies indexed under Premature Birth.
Median enrollment 58 across the 54 interventional studies, 150 across the 46 observational. Of the 57 that completed or were terminated, 8 (14%) have results posted.
This tab as a report to print or save as PDF → With an account.
8 of 100 have an industry lead sponsor. The 10 most frequent:
King's College Hospital NHS Trust is the lead sponsor of 171 studies on the registry; 56 are open to participants now.
King's College Hospital NHS Trust has 6 studies filed under Premature Birth — fewer than ten, so there is no comparison to draw.
11 of the studies in Premature Birth with a site in United Kingdom that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03168516Phase 3University Hospital TuebingenEffects of Closed-loop Automatic Control of FiO2 in Extremely Preterm Infants | 2026-12 |
| NCT04372953Murdoch Childrens Research InstitutePositive End-Expiratory Pressure (PEEP) Levels During Resuscitation of Preterm Infants at Birth (The POLAR Trial). | 2026-11-30 |
| NCT06705257South Tees Hospitals NHS Foundation TrustPEEP FOR LUNG RECRUITMENT IN PRETERM INFANTS-EIT STUDY | 2026-12-31 |
| NCT05306925University of LiverpoolAn Exploratory Study of Arginine Supplementation and the Postoperative Immune REsponse | 2026-12-31 |
| NCT06823115Indiana UniversityAssessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0 | 2027-01 |
Add all 11 to your calendar (.ics) → With an account.
Among the 100 studies in Premature Birth with a site in United Kingdom, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Preterm infants are at higher risk of long-term respiratory problems and abnormal lung function in childhood. Respiratory support including mechanical ventilation, that is the use of a machine to move air into and out of the lungs, and oxygen treatment may further increase the risk of complications. In a randomised controlled trial, closed-loop automated oxygen control (CLAC) was associated with reductions in the duration of mechanical ventilation and oxygen treatment and may, therefore, help reduce long-term respiratory morbidity.
The effect of CLAC systems on lung function has not been explored to date. This prospective observational study aims to explore the effect of automated oxygen control during the neonatal period on lung mechanics in children who were born at less than 34 weeks of gestation and required mechanical ventilation.
The study will take place at King's College Hospital (KCH) children's outpatient department. Parents of children that participated in the randomised trial of automated versus manual oxygen control will be approached, informed and if appropriate consented to join the study.
The study will measure outcomes including lung mechanics and parent-reported respiratory morbidity (breathing difficulties, respiratory infections, hospital admissions after discharge from neonatal care). Results will be compared between the two groups.
Lung mechanics will be assessed using a technique called forced oscillation. This is a technique which involves the patient breathing through a face mask (if less than two years of age) or a mouthpiece filter (if older than two years). It is a non-invasive technique that measures lung function by superimposing gentle air pressure waves onto the patient's spontaneous breathing.An average of three measurements each one lasting up to 20 seconds will be performed.
Parents will be asked to fill in a questionnaire regarding the health of their child after discharge from the neonatal unit.
The study's duration will be 12 months.
Eligible infants will be identified from the recruitment log of the study 'Optimising ventilation in preterms with closed-loop oxygen control' (IRAS: 297749). These children were born between September 2021 and February 2025. Parents of all survivors will be approached via a phone call and/ or email by the investigators. The parents will be provided with an information sheet about the study via email. The researchers will answer questions over the phone/ via email and face-to-face during the appointment. Written informed consent will be obtained.
The children will be asked to attend the outpatient department at King's College Hospital when clinically well and without respiratory tract infections in the previous four weeks.
Demographic information will be obtained from the children's medical records including gestational age, birth weight, antenatal steroids, administration of surfactant, duration of mechanical ventilation and oxygen treatment, postnatal steroids, diagnosis of bronchopulmonary dysplasia, that is a chronic lung disease, and need for home oxygen.
Body weight and height at the time of testing will be measured and recorded. The Thorasys Tremoflo-C100 Airwave Oscillometry System TM (Thorasys, Montreal, QC, Canada) will be used with Thorasys software for children at or above two years of age. The device will measure lung resistance and reactance (compliance) at specific frequencies.
Patients will be assessed in a seated position with a nose clip in place and the investigator will support their cheeks and lower jaw. Children who cannot tolerate the nose clip will have their nose held by their accompanying parent/guardian. The participants will be breathing through a standard mouthpiece filter. Forced oscillometry testing will be performed for 20 seconds. Measurements will be repeated until a minimum of three valid tests is obtained. The mean results of at least two adequate measurements will be used for analysis.
For infants less than two years of age the TremoFlo N-100 Airwave Oscillometry System (Thorasys Thoracic Medical Systems Inc. Montreal, Quebec, Canada) will be used. The infants will be placed in supine position and will be breathing via a cushioned face mask covering the nose and mouth and a filter (Humid-Vent Filter Small, Teleflex Medical, Ireland). Measurements will be performed at the same frequencies as the older children.
Parents will be invited to fill in a questionnaire related to their child's health following discharge from the neonatal unit. This will include questions about duration of home oxygen treatment, frequency of breathing difficulties, any respiratory infections requiring antibiotics, hospital admissions and their reasons, and presence of smokers in the household.
All measurements will be completed during a single clinic visit on the same day and no follow up will be required.
Preterm-born children requiring mechanical ventilation at birth who participated in a randomised controlled trial of automated versus manual oxygen control.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Preterm-born children \<34 weeks gestation that participated in a randomised controlled trial of automated versus manual oxygen control in the early neonatal period will be included in the study. Lung mechanics will be measured via forced oscillometry technique at follow up.
Other: Forced oscillometry technique
Patients will be assessed in a seated position with a nose clip in place and the investigator will support their cheeks and lower jaw. Children who cannot tolerate the nose clip will have their nose held by their accompanying parent/guardian. The participants will be breathing through a standard mouthpiece filter. Each FOT will be performed for 20 seconds. Testing will be repeated until a minimum of three tests is obtained with coherence of variance (CoV) equal or less than 15% at R5. The mean results of at least two adequate measurements will be used for analysis. For infants less than two years of age the TremoFlo N-100 Airwave Oscillometry System (Thorasys Thoracic Medical Systems Inc. Montreal, Quebec, Canada) will be used. The infants will be placed in supine position and will be breathing via a cushioned face mask covering the nose and mouth and a filter (Humid-Vent Filter Small, Teleflex Medical, Ireland). Measurements will be performed at the same frequencies.
The increase in respiratory resistance (R) in centimeters water per liter per second of participants who received automated oxygen control in the neonatal period compared to those who received manual oxygen control.
Time frame: From enrollment to the end of monitoring at one hour.
The reduction in respiratory reactance (X) in centimeters water per liter per second of participants who received automated oxygen control in the neonatal period compared to those who received manual oxygen control.
Time frame: From enrollment to the end of monitoring at one hour.
To evaluate differences in the frequency of episodes of breathing difficulties (number of episodes per month) after discharge from neonatal care with the use of parent-questionnaires.
Time frame: From enrolment to the end of monitoring at one hour.
To evaluate differences in the absolute number of courses of antibiotics given for respiratory infections after discharge from neonatal care with the use of parent-questionnaires.
Time frame: From enrollment to the end of monitoring at one hour.
To evaluate differences in the absolute number of hospital readmissions after discharge from neonatal care with the use of parent-questionnaires.
Time frame: From enrollment to the end of monitoring at one hour.
Plan to share: No
Start is estimated for Oct 2026; primary completion for Oct 2027, 12 months later.
Of 373 non-industry observational studies under Premature Birth, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 63. This study's planned 12 months is below that.
Counting every sponsor, half of 388 studies reached it within 35 months; a quarter within 19 and three quarters within 61.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
King's College Hospital NHS Trust →